FDA approves first treatment for congenital athymia
Congenital athymia is a rare condition in which babies are born without a thymus. As a result, the immune...
How to know the status of acute lymphoblastic leukemia from epigenetic DNA modification?
Hematological cancers were among the first to be discovered to have abnormal demethylation status. Excretion of epigenetic DNA modification...
CRISPR gene editing: In search of perfection
In 2012, Biochemists Jennifer Doudna and Emmanuelle Charpentier made one of the most important discoveries in the history of...
Early-Life Antibiotic Exposure, Gut Microbiome, and Neurodevelopment
Over the past few decades, there has been a dramatic increase in the incidence of childhood neurodevelopmental disorders such...
Potential New Targets to Treat Acute Myeloid Leukemia
Researchers have discovered new therapeutic targets for acute myeloid leukemia (AML). A new study published in Stem Cells suggests...
FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...